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Introduction: Infection with the Burkholderia cepacia complex is an important cause of morbidity and mortality in cystic fibrosis (CF). We
investigated the molecular clock speed of the seven genes used in the multilocus sequence typing (MLST) scheme for these bacteria.
Methods: At least two isolates, separated by months to years, from each of 20 patients were typed using MLST. In total 41 isolates,
providing 128 isolate-years, were analyzed. Mutation and recombination rates were estimated assuming a Poisson distribution.
Results: Out of 20 patients, 15 had no change in sequence type over time (mean 7.07 years, range 1.09 to 14.24). One patient had strain
replacement. Three patients had evidence of recombination involving one of the seven housekeeping genes, and one patient had evidence of
recombination of two genes. The mutation rate was estimated as 2.36×10−6 per nucleotide per year (50% confidence limit) and 1.02×10−5
per nucleotide per year (upper 95% confidence limit). The rate of nucleotide changes due to recombination events was estimated as 0.676 to
0.839 per year (95% confidence limits).
Conclusions: B. cepacia complex housekeeping genes have a slow molecular clock speed and MLST provides a robust and reliable typing
technique for isolates from this complex. A low rate of point mutation was found, with a higher rate of recombination events, in keeping with
previous cross-sectional epidemiological data. The study also demonstrated, for the first time, recombination in a longitudinal in vivo study.
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The majority of morbidity and mortality in cystic fibrosis
(CF) is due to pulmonary disease [1], and infection with the
Burkholderia cepacia complex has a negative impact on
health; infected patients having a more rapid decline in lung
function, greater use of health care facilities, higher
mortality, and a risk of developing a necrotizing pneumonia
causing rapid loss of lung function followed by death⁎ Corresponding author. Tel.: +44 2476 523534; fax: +44 2476 523568.
E-mail address: c.g.dowson@warwick.ac.uk (C.G. Dowson).
1569-1993/$ - see front matter © 2006 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2006.10.003(known as cepacia syndrome) [2–4]. The B. cepacia
complex consists, at present, of a group of nine closely
related species (previously termed genomovars) [5], which
are found in many environmental niches and all of which
have been isolated from sputum samples from patients with
CF [4]. Replacement of one species with another from the
B. cepacia complex has been described in patients with CF
[6–8], as has replacement of one strain with another from
the same species within the complex. Bacterial populations
may have a predominantly clonal evolution, evolving by the
accumulation of point mutations, or a freely recombinational
evolution [9]. Studies of the B. cepacia complex have founded by Elsevier B.V. All rights reserved.
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recombine more than others (eg B. ambifaria) [10].
Typing techniques are crucial to our understanding of the
epidemiology of these bacteria. Since the genomic organi-
sation of a given strain may change rapidly under the
influence of mobile genetic elements such as insertion
sequences, transposons, plasmids or phages [11], techniques
based on restriction digestion or amplification of multiple
sections of DNA may give misleading results suggesting that
isolates are unrelated, when in fact they may share a very
close evolutionary relationship. Recently a multilocus
sequence typing (MLST) scheme for the B. cepacia complex
was published [10]. MLST utilizes the amplification by PCR
and DNA sequencing of seven putative housekeeping genes.Table 1
MLST results by patient and time
Alleles which have changed over time are highlighted in black, with probable i
between alleles is recorded in superscript (for example, in patient L, gltB hasThe method provides highly discriminatory information
from gene sequencing which can be shared and compared
easily between laboratories. Housekeeping genes were
chosen because they have very basic cellular functions and
should be under little selective pressure. They are thus
presumed to have a slow “molecular clock speed”, meaning
that they undergo mutations at a very low rate.
Precisely because it examines housekeeping genes which
undergomutations at a very low rate, theMLSTscheme should
be able to provide robust epidemiological information by
identifying strains based on their “core” evolutionary genome.
In contrast other techniques, such as macrorestriction of whole
genomic DNA by pulsed-field gel electrophoresis, provide
information about the whole of a bacterium's genome,nter-species recombination in grey. The number of nucleotide differences
changed from allele 20 to allele 11 which differed by 19 nucleotides).
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rate under selection pressure (ie have a higher molecular clock
speed). Such techniques have the advantage that they show
some of the rapid changes that occur in bacterial strains with
time but have the disadvantage that they may mask the close
evolutionary relationship between strains.
If the mutation rate of these housekeeping genes were
higher than expected, MLST would not be able to identify
the same strain reliably over time, or identify close
evolutionary relationships between strains. Ascertaining the
molecular clock speed of the seven genes is therefore
important and we investigated it by comparing paired B.
cepacia complex isolates from the same chronically infected
CF patients separated over several years.
2. Methods
2.1. Bacterial isolates
One to six colonies from a variety of culture media used
for the isolation of aerobic bacteria from respiratory samples
from patients with CF (including an agar selective for B.
cepacia complex) were subcultured to Columbia blood agar
plates in the British Columbia Children's Hospital microbi-
ology laboratory. Isolates presumptively identified as B.
cepacia complex were stored at −80 °C and identified by
phenotypic and molecular methods as described previously
[12], using the API 20NE system (Biomerieux, Marcy
L'etoile, France), classical oxidative/fermentative sugars
utilization, growth on BCSA [8], growth at 42 °C and
molecular tests based on genomovar specific primers
directed to the recA gene [13]. Morphologically different
colonies were analyzed separately. DNAwas extracted using
a bead-beater technique as previously described [14]. The
first and latest isolates from 20 patients chronically infected
with B. cepacia complex were analyzed using MLST.
2.2. Multilocus sequence typing
Typing of the isolates using the MLST scheme for B.
cepacia complex was performed as described previously
[10], and conditions and primers can be found at http://
pubmlst.org/bcc/info/protocol.shtml. Briefly, PCR was used
to amplify the seven housekeeping genes, which were then
sequenced using internal primers. The resulting nucleotide
sequences were analysed using SeqMan II (DNAStar). Each
allele was given an identifying number using the database on
the PubMLST website (http://pubmlst.org/bcc) and our own
database of isolates, and then each isolate was given an
overall sequence type (ST) number using the same databases.
2.3. Molecular clock speed
The number of point mutations and recombination events
in the housekeeping genes was assumed to follow a Poisson
distribution and confidence limits were calculated accordingto this method as described previously [15]. Briefly, the
Poisson distribution assumes that the length of time between
samples can be split into equally sized units so small that
they can contain either zero or one mutation, and that the
probability of a mutation occurring in any given time unit
remains constant. The probability of a certain number of
mutations occurring over a given time period can be
calculated using the formula p(k)=λk.e−λ /k!, where k is the
number of mutations, and λ is the expected number of
mutations (ie the number of time units multiplied by the
probability of a mutation in any given time unit).
3. Results
The results of MLST of the 41 B. cepacia complex
isolates from 20 patients are shown in Table 1 with their
allelic profiles and the number of nucleotide differences
between alleles where they had changed. In total 128 isolate-
years were represented. In 15 (75%) of the patients no
change in ST was found over time and the mean time
between collection dates for these patients was 7.07 years
(range 1.1 to 14.2). In five (25%) of the patients the ST
changed over the sampling period and the mean time
between collection dates for these patients was 4.4 years
(range 2.7 to 8.5).
Assuming a Poisson distribution for point mutations, an
observed number of zero point mutations over 106 years in
the 15 patients with no change in ST gave an upper 95%
confidence limit of 1.02×10−5 point mutations per nucle-
otide per year and a 50% confidence limit of 2.36×10−6
point mutations per nucleotide per year. Assuming the same
Poisson distribution for recombination events, an observed
number of 5 events over 119 years gave 95% confidence
limits of 0.015 to 0.091 recombination events per year in the
housekeeping genes. Expressed as the number of nucleotide
changes due to recombination events, the 95% confidence
limits for 90 observed changes were 0.676 to 0.839 per year.
This calculation used data from all patients except patient E,
in whom strain replacement had occurred. It also assumed
the following number of recombination events: 2 events for
patient J, and 1 event for patients B, D and L.
4. Discussion
4.1. Mutation, recombination, and new infection
In patient E all seven alleles were different between the
two isolates, indicating that a new strain had replaced the
previous one, though it belonged to the same species (B.
cenocepacia recA lineage IIIB). Replacement of one strain
by another of the same species has been described previously
[6].
In patient B (B. multivorans), and patients D and L (both B.
vietnamiensis) all but one allele remained constant over time.
The numbers of nucleotides which were different were 22, 41
and 19, respectively. A recombination event involving one
218 D.J. Waine et al. / Journal of Cystic Fibrosis 6 (2007) 215–219gene is a far more likely explanation for this difference than
multiple point mutations in one gene while the other six
remained unchanged. Recombination has been described
previously in cross-sectional studies of theB. cepacia complex
[5,10,16] but not, to our knowledge, from a longitudinal study
within a patient. It is noteworthy that in the cross-sectional
studies,B. multivorans and B. vietnamiensiswere both species
within the B. cepacia complex which appeared to be more
freely recombining than others. Interestingly, 2 of these
recombination events appear to be inter-species, because trpB-
147 (patient B) and gltB-11 (patient L) are typically associated
with B. cenocepacia recA lineage IIIA strains.
How did recombination occur in these patients? One
possibility is that transient infection with a new strain of B.
cepacia complex allowed recombination and that the new
strain was subsequently either eradicated (due to competition
from the established strain) or remained present in only a very
low population density compared to the established strain.
Transient infection with more than one strain has been
described [6,17]. Another possibility is that infection is an on-
going dynamic process with regular inhalation of bacteria
from the environment, such that recombination may have
occurred outside the patient before inhalation. However, if
this was the case, a greater frequency of change in strains
would be expected as patients move between environments
over their lives.
A further possibility is that the patients were permanently
infected with two or more strains of B. cepacia complex and
that, by chance, different strains were picked at the two time
points. This is a possibility that affects all longitudinal
investigations. Even if multiple colonies from sputum
samples are typed, the chance of detecting both strains
depends on the ratio of their numbers. For example, if the
ratio was 100:1, the chance of finding both strains would
only be 11% if 12 colonies were picked. However, since a
previous study using RAPD typing of multiple colonies
found only 0–5% of patients were co-infected [17], our
finding of sequence type changes in 25% of patients is
unlikely to be due to the random selection of different strains
from lung infected by multiple strains.
In patient D the gltB gene could not be amplified for
sequencing. This gene is very close to gyrB on the chromo-
some, so amplification probably failed because the site of the
amplification primers had been disrupted by the recombina-
tion event evidenced by the change in gyrB.
In patient J five of the alleles remained constant over time.
The atpD gene changed from allele 15 to allele 16 (a dif-
ference of 1 nucleotide) and the gyrB gene changed from
allele 180 to allele 10 (a difference of 7 nucleotides). Re-
combination is likely to have occurred for gyrB, for the
reasons given above. For atpD, however, it could be argued
that a difference of 1 nucleotide is more likely to represent a
point mutation than a recombination event. In a previous
study of N. meningitidis alleles differing by 1 nucleotide
were assumed to represent point mutations [18], though the
possibility of recombination having occurred with an allelethat differed by only one nucleotide was also considered. In
fact, the authors assert that point mutations are more likely to
produce novel alleles (ie alleles not already present in the
species and therefore not represented in an MLST dataset)
whereas recombination more often produces alleles that are
already present in the species and therefore the dataset.
Among the 168 B. cenocepacia IIIA isolates analyzed by our
laboratory (data not shown), 49% contained atpD-15 and
45% contained atpD-16, so any change in atpD resulting in
either allele 15 or 16 is very likely to have occurred by
recombination rather than point mutation.
4.2. Molecular clock speed
Previous studies have demonstrated that patients usually
harbour the same strain over a long period of time [14,19]. In
this study the majority of patients (15 out of 20) had no
change in sequence type over time (mean 7.07 years, range
1.09 to 14.24). Analysis confined to these patients led to
molecular clock speed estimates of 2.36×10−6 mutations per
nucleotide per year (50% confidence limit) or 1.02×10−5
mutations per nucleotide per year (upper 95% confidence
limit), which is of the same order as that found using the
same methodology for H. pylori [15], but higher than
estimates for E. coli [20].
One patient had evidence of infection with a new strain,
three patients had evidence of recombination involving a
single gene, and one patient had evidence of recombination
involving two genes. Thus, excluding the patient in whom
infection with a new strain was found, a total of 5 recom-
bination events was found over a total of 119 years, leading
to recombination rate estimates of 0.015 to 0.091 per year
(95% confidence limits), or changes in 0.676 to 0.839 nuc-
leotides per year due to recombination events. This assumes
only one event between the first and the most recent isolate
from a given patient, when others may have occurred in the
same gene in the intervening years without being detected.
Furthermore, the Poisson distribution assumes only one
nucleotide can change per unit time, whereas recombination
can cause several changes at once. Nevertheless, it was
useful to provide an estimate over a longer period of time to
enable a direct comparison between the rate of nucleotide
changes due to point mutation and the rate due to recom-
bination; nucleotide changes being far more likely to have
occurred as a result of recombination than point mutation.
This result should not be assumed to hold across the whole
B. cepacia complex because the sample includes only a
few isolates each from B. cenocepacia recA lineages IIIA
and IIIB, B. multivorans and B. vietnamiensis; other species
from the complex may behave differently.
5. Conclusions
This study demonstrated that the seven housekeeping
genes used in the B. cepacia complex MLST scheme have a
slow molecular clock speed and that MLST provides a robust
219D.J. Waine et al. / Journal of Cystic Fibrosis 6 (2007) 215–219and reliable typing technique for B. cepacia complex
specimens isolated from CF sputum. A low rate of point
mutation was found, with a higher rate of recombination
events, in keeping with previous cross-sectional epidemio-
logical data. The study also demonstrated recombination for
the first time in an in vivo longitudinal study.
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